Status:
COMPLETED
A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19
Lead Sponsor:
Beech Tree Labs, Inc.
Collaborating Sponsors:
Norwich Clinical Research Associates Ltd.
Curavit Clinical Research
Conditions:
SARS-CoV-2 Infection
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
Clinical trial to compare sublingual low does thimerosal in adults that have symptoms of SARS-CoV-2 Infection against placebo to show a difference in physical characteristics and viral levels.
Eligibility Criteria
Inclusion
- 40 years of age or older
- Provide written informed consent
- Have a SARS-COV-19 diagnostic test with positive results
Exclusion
- Having an oxygen saturation level below 92% at baseline or currently on Oxygen therapy
- Subjects currently hospitalized
- Subjects who have received a COVID vaccination
- Subjects with a diagnosis of immunodeficiency
Key Trial Info
Start Date :
July 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04522830
Start Date
July 30 2020
End Date
February 28 2021
Last Update
April 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intermountain Clinical Reserach
Draper, Utah, United States, 84020